Hologic (HOLX)
(Delayed Data from NSDQ)
$71.79 USD
-0.35 (-0.49%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $71.80 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
Brokerage Reports
Hologic, Inc. [HOLX]
Reports for Purchase
Showing records 381 - 400 ( 417 total )
Company: Hologic, Inc.
Industry: Medical - Instruments
Medical Technology: Thoughts on Our Medical Technology Universe Heading Into the Dog Days of Summer
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
Company: Hologic, Inc.
Industry: Medical - Instruments
HOLX: Youre Buying What?? Four Reasons We Dont Like the Gen Probe Deal Downgrading to NEUTRAL
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
HOLX: C View Update From Oslo Study at ECR Meeting in Vienna
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
HOLX: Our Consultant Positive on Oslo Study We Believe the Inflection Point for Tomosynthesis Adoption is Just Around the Corner Upgrading to BUY
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
Company: Hologic, Inc.
Industry: Medical - Instruments
HOLX: Model Update, Adjusting PT Slightly Higher on Better Sentiment, Looking to March Data from Oslo Study
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: Hologic, Inc.
Industry: Medical - Instruments
Company: Hologic, Inc.
Industry: Medical - Instruments
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: Hologic, Inc.
Industry: Medical - Instruments
Expect HOLX to Track to Plan; Thus, We Look for an In Line 1QF12
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: Hologic, Inc.
Industry: Medical - Instruments
HOLX: Waiting for the Inflection Point on Dimensions Tomosynthesis Initiating Coverage of Hologic with a Neutral Rating, $19 PT
Provider: COLLIERS SECURITIES
Company: Hologic, Inc.
Industry: Medical - Instruments
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: Hologic, Inc.
Industry: Medical - Instruments
HTA Receives FDA Clearance, Allowing Diagnostics to "Hold its Own"
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: Hologic, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: Hologic, Inc.
Industry: Medical - Instruments
RSNA 2011, Day 2: A Busier Day on the Floor, HOLX Grows Portfolio
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: Hologic, Inc.
Industry: Medical - Instruments
Steady Traffic on the Exhibit Floor; HOLX Keeps 3D U.S. Lead
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V
Company: Hologic, Inc.
Industry: Medical - Instruments
Company: Hologic, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: Hologic, Inc.
Industry: Medical - Instruments
F4Q11 Earnings Beat; F2012 Guidance Appears to Reflect Some Conservatism
Provider: KAUFMAN BROTHERS
Analyst: CERVANTES V